Psychedelics media and events company Delic Holdings (CSE: DELC) (OTCQB: DELCF) is taking its first steps into patient treatment with the acquisition of two ketamine infusion treatment clinics.
The clinics are operated by Ketamine Infusion Centers LLC, and located in Phoenix, Arizona and. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
Algernon Pharmaceuticals Announces Increase and Close of Private Placement globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Share:
VANCOUVER, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (CSE:AGN) (FRANKFURT: AGW) (OTCQB:AGNPF) (the Company or Algernon ) a clinical stage pharmaceutical development company is pleased to announce that it has appointed Dr. Christopher Bryan PhD as Vice President, Research & Operations and Dr. Ahmad Khalil MD, PhD as the Company s Chief Medical Officer.
Dr. Christopher Bryan graduated from the University of Toronto, with a PhD in organic chemistry and brings significant skills and experience to Algernon. His background as a scientist and senior manager includes the synthesis of hundreds of novel small molecules as potential therapeutic agents, the coordination of regional commercial teams and internal departments (i.e., marketing, R&D, manufacturing, sales and regulatory affairs), and the management of multiple strategic relationships including those involving key opinion leaders. He also has extensive experience in scientific wri
Feb 18, 2021
Richard Dal Monte, Market One Media According to the CDC, in 2018, 1 in every 6 deaths from cardiovascular disease was due to stroke. , Image courtesy of Market One Media
Pre-clinical testing of DMT has shown promise for stroke patients with Phase 1 human trials planned for 2021
Algernon Pharmaceuticals is focusing on the potential for sub-psychedelic amounts of the psychedelic to possibly help stroke patients without subjecting them to âtripsâ
Algernon, a drug repurposing company, is also testing the established drug Ifenprodil as a possible treatment for COVID-19
Attitudes towards current or former illicit drugs are rapidly changing worldwide. Dozens of countries and 16 U.S. states have legalized personal possession and consumption of cannabis even as research expands into its possible health applications.